GENETICISTS UNVEIL MAIDEN WHOLE GENOME SEQUENCING TEST IN EMBRYOS AT PARIS CONFERENCE

KUALA LUMPUR, April 19 (Bernama) -- Dr Santiago Munné, a pioneer in preimplantation genetic diagnosis, presented the first whole genome sequencing test in embryos before delegates at the 20th Conference of the Preimplantation Genetic Diagnosis International Society (PGDIS), held in Paris.

In his plenary address attended by over 300 experts, Dr Munné, an internationally recognised trailblazer in reproductive genetics, presented validation data for GenomeScreen, the test developed by the research team he leads at the biotechnology firm GenEmbryomics.

GenomeScreen is a revolutionary new whole genome sequencing test for In Vitro Fertilisation (IVF) embryos that has been described as "the most complete genetic test in IVF" by authorities at the PGDIS forum.

The test provides highly precise information on the genome sequence of the embryo and the genetic parents, offering families key preimplantation insights on embryo health and reproductive prognosis that can inform their decisions.

Furthermore, this information will be invaluable to individuals born from IVF, as it will provide input on nutrigenomics or guidance on which medicines are most genetically suited to the patient.

“When we first started our research on embryo sequencing, our goal was to create a powerful, comprehensive tool that could equip fertility physicians with exhaustive data for precision screening.

“Now that we have this tool and use it with 99 per cent reliability, we are aware that this diagnosis not only provides information, but also substantially enhances the success of reproductive medicine,” said GenEmbryomics founder, Dr Nick Murphy in a statement.

Dr Munné, whose career as a leader in reproductive genetics spans over 20 years, has made enormous contributions to embryo selection and IVF treatment. With this test, he and his team of researchers solidify the role of genetic testing within reproductive medicine, increasing treatment success.

Founded by Dr Murphy in 2019, GenEmbryomics is a cutting-edge biotech company specialising in the genomic analysis of embryos to determine the most viable candidates for IVF implantation.

--  BERNAMA